St. Luke’s Cancer Institute (SLCI) brings cutting-edge clinical trials to Idaho and the Northwest. A member of Children’s Oncology Group, SLCI provides access to experimental treatments usually only available at hospitals in larger metropolitan areas. Clinical trials often require participating hospitals to invest in specialized medical equipment and prescribe expensive, experimental therapies not covered by patients’ medical insurance. Funds contributed by KTM cover these research-related costs, enabling patients and St. Luke’s Cancer Institute itself to participate in studies they could not otherwise afford.
Advancing a Cure
The Killebrew-Thompson Memorial is dedicated to raising funds for leukemia and cancer research. Proceeds from our annual charity event help to advance cancer research and care at Masonic Cancer Center, University of Minnesota in Minneapolis and St. Luke’s Cancer Institute in Boise, Idaho.
To date KTM has donated more than $21.4 million, which has gone directly to cancer research. Our beneficiaries leverage these funds three- to five-fold through matching grant, increasing the impact of our annual contribution to the million-dollar mark.
Masonic Cancer Center (MCC) is advancing cancer care beyond the chemotherapy and radiation treatments of the past. Designated by the National Cancer Institute as a comprehensive cancer center, one of only 51 institutions in the country, MCC is preeminent in the research of cell therapies to treat leukemia and solid tumor cancers. It is the first to treat cancer patients with gene modified off-the-shelf Natural Killer (NK) cells. Support from KTM seeds high impact studies that contribute to the worldwide research community and improve quality of life for patients and survivors.